Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198.

Saved in:
Bibliographic Details
Title: Radioprotection of IDH1-Mutated Cancer Cells by the IDH1-Mutant Inhibitor AGI-5198.
Authors: Molenaar RJ; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. r.j.molenaar@amc.nl., Botman D; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Smits MA; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Hira VV; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., van Lith SA; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Stap J; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Henneman P; Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Khurshed M; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Lenting K; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Mul AN; Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Dimitrakopoulou D; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., van Drunen CM; Department of Otorhinolaryngology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Hoebe RA; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Radivoyevitch T; Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio., Wilmink JW; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Vandertop WP; Department of Neurosurgery, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. Department of Neurosurgery, VU Medical Center, Amsterdam, the Netherlands., Leenders WP; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Bleeker FE; Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands., van Noorden CJ; Department of Cell Biology and Histology, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.
Source: Cancer research [Cancer Res] 2015 Nov 15; Vol. 75 (22), pp. 4790-802. Date of Electronic Publication: 2015 Sep 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1538-7445
DOI:10.1158/0008-5472.CAN-14-3603